These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20881036)

  • 1. Inhibition of chymase protects against diabetes-induced oxidative stress and renal dysfunction in hamsters.
    Maeda Y; Inoguchi T; Takei R; Sawada F; Sasaki S; Fujii M; Kobayashi K; Urata H; Nishiyama A; Takayanagi R
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1328-38. PubMed ID: 20881036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
    Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chymase inhibitor improves survival in hamsters with myocardial infarction.
    Hoshino F; Urata H; Inoue Y; Saito Y; Yahiro E; Ideishi M; Arakawa K; Saku K
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S11-8. PubMed ID: 12688390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.
    Ohshiro Y; Ma RC; Yasuda Y; Hiraoka-Yamamoto J; Clermont AC; Isshiki K; Yagi K; Arikawa E; Kern TS; King GL
    Diabetes; 2006 Nov; 55(11):3112-20. PubMed ID: 17065350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
    Hendarto H; Inoguchi T; Maeda Y; Ikeda N; Zheng J; Takei R; Yokomizo H; Hirata E; Sonoda N; Takayanagi R
    Metabolism; 2012 Oct; 61(10):1422-34. PubMed ID: 22554832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models.
    Miyazaki M; Takai S; Jin D; Muramatsu M
    Pharmacol Ther; 2006 Dec; 112(3):668-76. PubMed ID: 16837049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chymase inhibition prevents myocardial fibrosis through the attenuation of NOX4-associated oxidative stress in diabetic hamsters.
    Maeda Y; Inoguchi T; Takei R; Hendarto H; Ide M; Inoue T; Kobayashi K; Urata H; Nishiyama A; Takayanagi R
    J Diabetes Investig; 2012 Aug; 3(4):354-61. PubMed ID: 24843590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice.
    Xu S; Jiang B; Maitland KA; Bayat H; Gu J; Nadler JL; Corda S; Lavielle G; Verbeuren TJ; Zuccollo A; Cohen RA
    Diabetes; 2006 Jan; 55(1):110-9. PubMed ID: 16380483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the selective chymase inhibitor TEI-F00806 on the intrarenal renin-angiotensin system in salt-treated angiotensin I-infused hypertensive mice.
    Ansary TM; Urushihara M; Fujisawa Y; Nagata S; Urata H; Nakano D; Hirofumi H; Kitamura K; Kagami S; Nishiyama A
    Exp Physiol; 2018 Nov; 103(11):1524-1531. PubMed ID: 30137655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of chymase-dependent angiotensin II formation to the progression of tubulointerstitial fibrosis in obstructed kidneys in hamsters.
    Fan YY; Nishiyama A; Fujisawa Y; Kobori H; Nakano D; Matsuura J; Hase N; Hitomi H; Kiyomoto H; Urata H; Kohno M
    J Pharmacol Sci; 2009 Sep; 111(1):82-90. PubMed ID: 19721329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
    Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy.
    Hamada Y; Miyata S; Nii-Kono T; Kitazawa R; Kitazawa S; Higo S; Fukunaga M; Ueyama S; Nakamura H; Yodoi J; Fukagawa M; Kasuga M
    Nephrol Dial Transplant; 2007 Jun; 22(6):1547-57. PubMed ID: 17360766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase.
    Fujii M; Inoguchi T; Sasaki S; Maeda Y; Zheng J; Kobayashi K; Takayanagi R
    Kidney Int; 2010 Nov; 78(9):905-19. PubMed ID: 20686447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation.
    Luo ZF; Feng B; Mu J; Qi W; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
    Toxicol Appl Pharmacol; 2010 Jul; 246(1-2):49-57. PubMed ID: 20399799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chymase inhibition protects diabetic rats from renal lesions.
    Zhang M; Huang W; Bai J; Nie X; Wang W
    Mol Med Rep; 2016 Jul; 14(1):121-8. PubMed ID: 27176496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension.
    Peixoto EB; Pessoa BS; Biswas SK; Lopes de Faria JB
    Am J Nephrol; 2009; 29(4):309-18. PubMed ID: 18849601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
    Björck S
    Scand J Urol Nephrol Suppl; 1990; 126():1-51. PubMed ID: 2194280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic applications of chymase inhibitors in cardiovascular diseases and fibrosis.
    Takai S; Jin D; Muramatsu M; Okamoto Y; Miyazaki M
    Eur J Pharmacol; 2004 Oct; 501(1-3):1-8. PubMed ID: 15464056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.